kynurenic acid has been researched along with Clerambault Syndrome in 2 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "CSF kynurenine and KYNA were compared to CSF cytokine levels, acute and long-term neurologic complications, and long-term cognitive impairments." | 5.46 | Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria. ( Bangirana, P; Engberg, G; Färnert, A; Franzén-Röhl, E; Holmberg, D; Idro, R; John, CC; Opoka, RO; Schwieler, L; Sellgren, CM; Wickström, R, 2017) |
| "CSF kynurenine and KYNA were compared to CSF cytokine levels, acute and long-term neurologic complications, and long-term cognitive impairments." | 1.46 | Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria. ( Bangirana, P; Engberg, G; Färnert, A; Franzén-Röhl, E; Holmberg, D; Idro, R; John, CC; Opoka, RO; Schwieler, L; Sellgren, CM; Wickström, R, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lun, J | 1 |
| Li, Y | 1 |
| Gao, X | 1 |
| Gong, Z | 1 |
| Chen, X | 1 |
| Zou, J | 1 |
| Zhou, C | 1 |
| Huang, Y | 1 |
| Zhou, B | 1 |
| Huang, P | 1 |
| Cao, H | 1 |
| Holmberg, D | 1 |
| Franzén-Röhl, E | 1 |
| Idro, R | 1 |
| Opoka, RO | 1 |
| Bangirana, P | 1 |
| Sellgren, CM | 1 |
| Wickström, R | 1 |
| Färnert, A | 1 |
| Schwieler, L | 1 |
| Engberg, G | 1 |
| John, CC | 1 |
2 other studies available for kynurenic acid and Clerambault Syndrome
| Article | Year |
|---|---|
Kynurenic acid blunts A1 astrocyte activation against neurodegeneration in HIV-associated neurocognitive disorders.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Astrocytes; HIV; HIV Infections; Kynurenic Acid; M | 2023 |
Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria.
Topics: Child; Child, Preschool; Cognition; Coma; Female; Humans; Infant; Kynurenic Acid; Kynurenine; Malari | 2017 |